Cart
sales@molnova.com
GLYCODEOXYCHOLIC ACID
CAS No. 360-65-6
GLYCODEOXYCHOLIC ACID( —— )
Catalog No. M20099 CAS No. 360-65-6
Glycodeoxycholic Acid is a bile acid that induces severe pancreatitis in rats. It can induce the apoptosis of SMMC-7721 cells.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 30 | In Stock |
|
| 100MG | 28 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 60 | In Stock |
|
| 1G | 88 | In Stock |
|
Biological Information
-
Product NameGLYCODEOXYCHOLIC ACID
-
NoteResearch use only, not for human use.
-
Brief DescriptionGlycodeoxycholic Acid is a bile acid that induces severe pancreatitis in rats. It can induce the apoptosis of SMMC-7721 cells.
-
DescriptionGlycodeoxycholic Acid is a bile acid that induces severe pancreatitis in rats. It can induce the apoptosis of SMMC-7721 cells.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number360-65-6
-
Formula Weight449.63
-
Molecular FormulaC26H43NO5
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESC[C@H](CCC(=O)NCC(O)=O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
2β-Methoxy-2-deethox...
2β-Methoxy-2-deethoxy-8-O-deacylphantomolin-8-O-tiglinate is a sesquiterpene lactone that can be isolated from Elephantopus mollis. 2β-Methoxy-2-deethoxy-8-O-deacylphantomolin-8-O-tiglinate exhibits cytotoxicity in mouse neuroblastoma B104 cells with an IC50 of 3.85 μM.
-
N-Formyl-Met-Ala-Ser
N-Formyl-Met-Ala-Ser is a peptide, binds to formyl peptide receptors on neutrophils.N-Formyl-Met-Ala-Ser Peptide (fMet-Ala-Ser) binds to formyl peptide receptors on neutrophils. N-Formylmethionine-containing peptides including the most potent and known member, N-formyl-Met-Leu-Phe (FMLP or fMet-Leu-Phe) stimulate human neutrophils by a receptor-dependent mechanism.
-
Ramucirumab
Ramucirumab is a human VEGFR-2 antagonist for the treatment of solid tumors,is also a fully human monoclonal antibody (IgG1) developed for the treatment of solid tumors.
